Action controls dopaminergic enhancement of reward representations

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7511-6. doi: 10.1073/pnas.1202229109. Epub 2012 Apr 23.

Abstract

Dopamine is widely observed to signal anticipation of future rewards and thus thought to be a key contributor to affectively charged decision making. However, the experiments supporting this view have not dissociated rewards from the actions that lead to, or are occasioned by, them. Here, we manipulated dopamine pharmacologically and examined the effect on a task that explicitly dissociates action and reward value. We show that dopamine enhanced the neural representation of rewarding actions, without significantly affecting the representation of reward value as such. Thus, increasing dopamine levels with levodopa selectively boosted striatal and substantia nigra/ventral tegmental representations associated with actions leading to reward, but not with actions leading to the avoidance of punishment. These findings highlight a key role for dopamine in the generation of appetitively motivated actions.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Analysis of Variance
  • Citalopram / administration & dosage
  • Citalopram / pharmacology*
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Corpus Striatum / physiology
  • Cues
  • Dopamine / metabolism*
  • Dopamine Agents / administration & dosage
  • Dopamine Agents / pharmacology
  • Double-Blind Method
  • Female
  • Fractals
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / pharmacology*
  • Magnetic Resonance Imaging / methods
  • Male
  • Psychomotor Performance
  • Punishment
  • Reward*
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Serotonin / metabolism
  • Substantia Nigra / drug effects
  • Substantia Nigra / metabolism
  • Substantia Nigra / physiology
  • Tegmentum Mesencephali / drug effects
  • Tegmentum Mesencephali / metabolism
  • Tegmentum Mesencephali / physiology
  • Time Factors
  • Young Adult

Substances

  • Dopamine Agents
  • Serotonin Uptake Inhibitors
  • Citalopram
  • Serotonin
  • Levodopa
  • Dopamine